特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
297272

中国のプレガバリン市場の分析

Investigation Report on Chinese Pregabalin Market, 2020-2024

出版日: | 発行: China Research and Intelligence | ページ情報: 英文 40 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
中国のプレガバリン市場の分析
出版日: 2020年09月30日
発行: China Research and Intelligence
ページ情報: 英文 40 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、中国のプレガバリン市場について調査分析し、主要メーカーの市場シェア、病院市場での販売価格、主要メーカーのプロファイル、特許の状況、病院市場での市場シェア(剤形別)などを提供して、概略以下の構成でお届けいたします。

第1章 プレガバリンの関連概念

  • 適応
  • 世界市場の販売状況

第2章 中国におけるプレガバリンの市場概要

  • 中国へのプロセス
  • 主要メーカー
  • 特許の状況
  • 市場規模

第3章 中国におけるプレガバリンの売上高の分析

  • 総売上高
  • 売上高:地域別

第4章 中国におけるプレガバリンの主要メーカーの市場シェアの分析

第5章 中国におけるプレガバリン(剤形別)の市場規模の分析

第6章 中国の病院市場におけるプレガバリンの基準価格

第7章 中国のプレガバリン市場における主要メーカー

  • Pfizer Deutschland GmbH
  • Chongqing Succeway Pharmaceutical Co., Ltd.

第8章 中国のプレガバリン市場の見通し

  • 中国のてんかん発生率の動向
  • ジェネリック医薬品の状況
  • 市場規模の予測
  • 競合パターンの予測

図表

目次
Product Code: 2009435

Pregabalin is a new-generation drug for neuralgia treatment. In Jul. 2004, it was approved by the European Union to treat some epileptic seizures in adults. In Dec. 2004, it was approved by the U.S. Food and Drug Administration (FDA) to treat diabetic peripheral neuralgia and postherpetic neuralgia. In 2006, generalized anxiety disorder and social anxiety disorder became new indications of Pregabalin. In 2007, Pregabalin was approved by the FDA as the first drug to treat fibromyalgia syndrome. In 2012, Pregabalin was approved by the FDA to treat spinal cord injury (SCI)-related pains. In 2010, Lyrica was approved to enter China.

According to CRI's research, the sales value of Lyrica increased by more than 700 times from about CNY 200,000 in 2010 to over 142.6 million in 2019. Due to Lyrica's success, many domestic manufacturers applied for Pregabalin production. Chongqing Succeway Pharmaceutical Co., Ltd.'s Pregabalin (trade name: Lairuike) was put in the market after obtaining the production license in 2013 and is gradually taking market share from Pfizer. By sales value, in 2019, Pfizer's Lyrica had a market share of approximately 68.1%, and the rest market share was captured by the products of Chongqing Succeway Pharmaceutical Co., Ltd. It is estimated that Pfizer's Lyrica will continue to dominate the Chinese market from 2020 to 2024 but its market share will decline because because the price of pregabalin produced by local Chinese companies is lower.

There is a continuous rise in the number of people suffering from indications for Pregabalin. For example, the number of epileptics in China has exceeded 10 million and increases by 500 thousand every year. Therefore, Pregabalin has a bright prospect in China.

Topics Covered:

  • Development environment of Chinese Pregabalin market 2015-2020
  • Governmental approval of Pregabalin in China
  • Sale value and volume of Pregabalin in China
  • Prices of Pregabalin in China by regions 2019-2020
  • Prices of Pregabalin in China by manufacturers 2019-2020
  • Major Pregabalin manufacturers and their market shares in China
  • Factors influencing the development of Chinese Pregabalin market
  • Prospects of Chinese Pregabalin market 2020-2024

Table of Contents

1 Relevant Concepts of Pregabalin

  • 1.1 Indication
  • 1.2 Development Process of Pregabalin in China
  • 1.3 Governmental Approval of Pregabalin in China
  • 1.4 Sales Value over the World

2 Market Overview of Pregabalin in China, 2013-2018

  • 2.1 Investigation on Sales Value of Pregabalin in China
    • 2.1.1 Total Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Investigation on Sales Volume of Pregabalin in China
    • 2.2.1 Total Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Investigation on Market Size of Pregabalin by Dosage Form in China, 2013-2018

3 Investigation on Market Share of Major Pregabalin Manufacturers in China, 2013-2018

  • 3.1 Major Manufacturers of Pregabalin
    • 3.1.1 Investigation on Market Share by sale value
    • 3.1.2 Investigation on Market Share by sale volume
  • 3.2 Pfizer
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales Value and Volume of Pregabalin Produced by Pfizer in China
  • 3.3 Chongqing Succeway Pharmaceutical Co., Ltd.
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales Value and Volume of Pregabalin Produced by Pfizer in China

4 Sales Price of Pregabalin in China Market, 2019

  • 4.1 Referential Price of Pregabalin in China Hospital Market
    • 4.1.1 Average Price in China
    • 4.1.2 Sales Price of Pregabalin by Region
  • 4.2 Referential Price of Pregabalin in China by Manufacturers
    • 4.2.1 Pfizer (Lyrica)
    • 4.2.2 Chongqing Succeway Pharmaceutical Co., Ltd. (Lairuike)

5 Prospect of Pregabalin Market, 2020-2024

  • 5.1 Factors influencing Pregabalin Market
    • 5.1.1 Driving Forces and Market Opportunities
    • 5.1.2 Threats and Challenges
  • 5.2 Generic Drugs
  • 5.3 Forecast on Market Size of Pregabalin in China, 2020-2024
  • 5.4 Forecast on Competition Pattern of Pregabalin in China

Selected List of Charts

  • Chart Important Events in Development Process of Pregabalin
  • Chart Governmental Approval of Pregabalin in China
  • Chart Patent Information About Pregabalin Registration
  • Chart Sales Value of Pregabalin over the World
  • Chart Sales Value of Pregabalin in China, 2015-2019
  • Chart Sales Value of Pregabalin in Different Regions of China, 2015-2019
  • Chart Sales Volume of Pregabalin in China, 2015-2019
  • Chart Sales Volume of Pregabalin in Different Regions of China, 2015-2019
  • Chart Dosage form of Pregabalin in China 2015-2019
  • Chart Market Share of Pregabalin in China by sale value, 2015-2019
  • Chart Enterprise Profile of Pfizer Inc.
  • Chart Sales Value and Volume of Pregabalin Produced by Pfizer, 2015-2019
  • Chart Enterprise Profile of Chongqing Succeway Pharmaceutical Co., Ltd.
  • Chart Sales Value and Volume of Pregabalin Produced by Pfizer, 2015-2019
  • Chart Average Price of Pregabalin in China Market, 2015-2019
  • Chart Sales Price of Pregabalin by Region in China, 2019
  • Chart Referential Prices of Pregabalin Produced by Pfizer GmbH Arneimittelwerk (GE) in China, 2019
  • Chart Referential Prices of Pregabalin Produced by Chongqing Succeway Pharmaceutical Co., Ltd. in China, 2019
  • Chart Pregabalin Products Under NMPA's Approval by the End of 2020
  • Chart Forecast on Sales Value of Pregabalin in China, 2020-2024
  • Chart Forecast on Sales Volume of Pregabalin in China, 2020-2024
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.